-+ 0.00%
-+ 0.00%
-+ 0.00%

Neurizon appoints Ross Murdoch independent non-executive director

PUBT·05/10/2026 23:32:05
Listen to the news
Neurizon appoints Ross Murdoch independent non-executive director
  • Neurizon appointed Ross Murdoch as independent non-executive director, effective immediately, as it advances NUZ-001 in the HEALEY ALS Platform Trial.
  • Murdoch brings more than 30 years of pharmaceutical and biotech leadership, including senior roles at AstraZeneca, GlaxoSmithKline, Shire Pharmaceuticals; currently CEO and president of Extractas Bioscience.
  • Michael Thurn retired from board, effective immediately, following previously announced transition from managing director and CEO.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurizon Therapeutics Ltd. published the original content used to generate this news brief on May 10, 2026, and is solely responsible for the information contained therein.